GSK256471
GSK256471 is a non-peptide tachykinin NK3 receptor antagonist with a pKi of 8.9 for the human recombinant NK3 receptor and 8.4 for the guinea pig native receptor. GSK256471 exhibits >100-fold selectivity for NK1 (pKi = 5.2) and NK2 (pKi = 7.3) receptors. GSK256471 noncompetitively inhibits neurokinin B (NKB) -induced inositol phosphate accumulation, and this inhibition is irreversible. GSK256471 inhibits wet dog shaking behavior and suppresses dopamine release. GSK256471 could be used to study schizophrenia[1][2].
Product Specifications
CAS Number
1133706-08-7
UNSPSC
12352005
Target
Neurokinin Receptor
Related Pathways
GPCR/G Protein; Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Smiles
O=C(N[C@H](C1=CC=CC=C1)C2CC2)C3=C(C(C4=CC=CC=C4)=NC5=CC=CC=C35)CN(S(=O)(C)=O)C
Molecular Formula
C29H29N3O3S
Molecular Weight
499.62
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
NK3R
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Epstein-Barr Virus (LMP-1) (CS2), CF405S conjugate, 0.1mg/mL
CD4 (T-Helper/Inducer Cell Marker) (CD4/1604), CF488A conjugate, 0.1mg/mL
Recombinant Neuropilin-1/NRP1/CD304 Monoclonal Antibody
